Randall's Plaque Study: Pathogenesis and Relationship to Nephrolithiasis
NCT ID: NCT00169806
Last Updated: 2025-01-23
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
NA
600 participants
INTERVENTIONAL
1998-11-30
2025-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The most common type of kidney stones contains calcium, which sometimes is attached to a part of the kidney important in producing the final urine, called the papilla. The investigators have noticed that persons who form kidney stones seem to have more papilla with stones attached. They propose to study these areas of the papilla, called Randall's plaques (named after their discoverer), in patients undergoing surgery for kidney stones.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Attached Stone Project: Do Calcium Oxalate Renal Calculi Originate From Randall's Plaque?
NCT00169754
The Role Of FGF23, Klotho, And Sclerostin In Kidney Stone Formers
NCT01526304
Ultrasound Imaging of Kidney Stones and Lithotripsy
NCT02214836
Brushite Kidney Stones: A Registry and Database of Clinical and Laboratory Findings
NCT00169663
Mobile Health Platform for Surveillance of Kidney Stone
NCT05389982
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
cohort
Subjects who are scheduled to undergo a percutaneous kidney stone removal who do not have complicated comorbidities
videotape for mapping of renal anatomy and papillary biopsy
Subjects who enroll in this study will have their renal anatomy videotaped for mapping purposes. Stone location and characteristics will be documented as will papilla and calyces. One or more papillary biopsies will be taken for analysis.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
videotape for mapping of renal anatomy and papillary biopsy
Subjects who enroll in this study will have their renal anatomy videotaped for mapping purposes. Stone location and characteristics will be documented as will papilla and calyces. One or more papillary biopsies will be taken for analysis.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Upper urinary tract endoscopic or PERC procedure for kidney stones removal
* General medical health allowing surgical procedure
* Ability to complete all the necessary components of the study
* Able to sign an informed consent
Exclusion Criteria
* Bleeding diathesis
* Inability or unwillingness to comply with post-surgical follow-up
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Indiana University School of Medicine
OTHER
University of Chicago
OTHER
Indiana Kidney Stone Institute
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
James Lingeman
James Lingeman, MD
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
James Lingeman, MD
Role: PRINCIPAL_INVESTIGATOR
IU Health Physicians Urology
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
IU Health North Hospital
Indianapolis, Indiana, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
98-073
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.